Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

A Korean target trial emulation found that starting antidiabetic medication within 12 months of newly crossing type 2 ...

Researchers awarded $8M grant to study long-term impact of Type 2 diabetes treatment for pregnant patients and their children ...

Millions of people with type 2 diabetes could receive better treatment thanks to a new, simple low-cost tool, according to research announced at the Diabetes UK Professional Conference 2025 and ...

Europe's Committee for Medicinal Products for Human Use has recommended several products for approval, including Novo Nordisk's diabetes drug Kyinsu and Bayer's menopause treatment Lynkuet. (European ...

Type 2 diabetes causes high blood sugar when your body does not produce enough insulin. Dietary changes and exercise helps prevent serious complications. Some people may have prediabetes, which occurs ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

Topical corticosteroids for the treatment of dermatologic conditions are not associated with an increased risk for incident type 2 diabetes.

People with diabetes suffer from depression more frequently than average. Researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim ...

Type 2 diabetes boosts the risk of infections like cellulitis. This higher risk may be due to several factors, such as the effects of diabetes on the immune system and the skin. Without treatment, ...